Skip to content

Clinical trials

Phase 2 Gastrointestinal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 2 Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20044
20063
20072
20081
20093
20105
20113
20123
20131
20146
20154
20161
20174
20184
20196
20204
20215
20228
20236
20242
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Recruiting18
Unknown status13
Terminated11
Not yet recruiting4
Active, not recruiting4
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center7
National Cancer Institute (NCI)5
Amgen3
Catalysis SL2
GlaxoSmithKline2
National Institutes of Health Clinical Center (CC)2
Royal Marsden NHS Foundation Trust2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Tianjin Medical University Cancer Institute and Hospital2
AHS Cancer Control Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms94
Colorectal Neoplasms18
Neoplasms16
Breast Neoplasms14
Digestive System Neoplasms14
Gastrointestinal Diseases12
Digestive System Diseases11
Esophageal Neoplasms10
Pancreatic Neoplasms10
Neoplasm Metastasis9

Trials

Showing 51 to 75 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.